ATG10 and colorectal carcinoma: However, ATG5 has been reported to be downregulated in 95% of CRC cases, although its expression increases with invasion into lymphovascular tissue (Cho et al., 2012); also, ATG10 upregulation correlates with tumor lymph node metastasis and invasion in CRC tissues (Jo et al., 2012).